Sanofi Showcases Long-Term Benefits Of Dupixent For Severe Asthma

Another Boost For Blockbuster

inhaler
Dupixent reduced rates of severe asthma attacks in extension study • Source: Shutterstock

More from Respiratory

More from Therapy Areas